| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Wednesday’s Close |
|---|---|---|---|---|---|
| ZTS | Zoetis Inc. | $88.3 | $42.55B | Downtrend |
Stocks making the biggest moves premarket: BAC, DVMT, WMT, HRS, LLL & more
https://www.cnbc.com/2018/10/15/stocks-making-the-biggest-move-premarket-bac-dvmt-wmt-hrs-lll--more.html
Oct 15, 2018 - Names on the move ahead of the open.
0
JAZZ or ZTS: Which Is the Better Value Stock Right Now?
http://www.zacks.com/stock/news/327129/jazz-or-zts-which-is-the-better-value-stock-right-now?cid=CS-ZC--327129
Oct 10, 2018 - JAZZ vs. ZTS: Which Stock Is the Better Value Option?
0
Investors Are Thinking Short Term - Cramer's Mad Money (9/24/18)
https://seekingalpha.com/article/4208082-investors-thinking-short-term-cramers-mad-money-9-24-18?source=feed_tag_cramers_picks
Sep 25, 2018 - Dimon said it's too soon for a banker to run for President.Elanco is expensive.Buy domestic casino stocks.
0
Cramer advises staying away from animal health play Elanco at these levels
https://www.cnbc.com/2018/09/24/cramer-stay-away-from-animal-health-play-elanco-at-these-levels.html
Sep 24, 2018 - Jim Cramer says that while his "humanization of pets" thesis remains intact, the newly public Elanco Animal Health is not the way to play it.
0
Elanco Animal Health - Good For Animals, Good Investment?
https://seekingalpha.com/article/4207907-elanco-animal-health-good-animals-good-investment?source=feed_tag_ipo_analysis
Sep 24, 2018 - Elanco Animal Health is the former animal health business from Eli Lilly.Following the successful spin-off of Zoetis from Pfizer, Lilly is pursuing the same strategy with initial success.Valuations in
1
Eli Lilly Prices Animal Health Unit IPO at $24 Per Share
http://www.zacks.com/stock/news/324124/eli-lilly-prices-animal-health-unit-ipo-at-%2424-per-share?cid=CS-ZC-FT-324124
Sep 20, 2018 - Lilly (LLY) prices Elanco IPO at $24 per share which is above the expected range of $20-$23 per share.
0
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Coca-Cola, Disney, BHP and Zoetis
http://www.zacks.com/stock/news/322408/the-zacks-analyst-blog-highlights-berkshire-hathaway-coca-cola-disney-bhp-and-zoetis?cid=CS-ZC-FT-322408
Sep 11, 2018 - The Zacks Analyst Blog Highlights: Berkshire Hathaway, Coca-Cola, Disney, BHP and Zoetis
0
Top Analyst Reports for Berkshire Hathaway, Coca-Cola & Disney
http://www.zacks.com/research-daily/181355/top-analyst-reports-for-berkshire-hathaway-coca-cola-disney?cid=CS-ZC-FT-181355
Sep 10, 2018 - Top Analyst Reports for Berkshire Hathaway, Coca-Cola & Disney
0
Hartline Investment Corp Buys Zoetis Inc, Pioneer Natural Resources Co, Marsh & McLennan ...
http://www.gurufocus.com/news/721543/hartline-investment-corp-buys-zoetis-inc-pioneer-natural-resources-co-marsh--mclennan-inc-sells-novo-nordisk-as-starbucks-corp-intel-corp
Aug 10, 2018 - Hartline Investment Corp Buys Zoetis Inc, Pioneer Natural Resources Co, Marsh & McLennan Inc, Sells Novo Nordisk A/S, Starbucks Corp, Intel Corp, Stocks: PXD,PYPL,FANG,ZTS,MMC,PLUG,INTC,MIDD,KO,PG,NVO,SBU, release date:Aug 10, 2018
0
Elanco Animal Health Files For U.S. IPO
https://seekingalpha.com/article/4196431-elanco-animal-health-files-u-s-ipo?source=feed_tag_ipo_analysis
Aug 08, 2018 - Elanco aims to spin out from parent Eli Lilly in a series of transactions including an IPO.The firm provides treatments, vaccines, and products for food and companion animals worldwide.When we learn f
0
Page 1>
Related Companies
| Name | Exchange | Price | Mkt Cap | |
| REGN | Regeneron Pharmaceuticals, Inc. | NASDAQ | $386.665 | $41.78B |
| VRTX | Vertex Pharmaceuticals Incorporated | NASDAQ | $175.8 | $44.93B |
| SHPG | Shire plc | NASDAQ | $176.25 | $46.08B |
| ALXN | Alexion Pharmaceuticals, Inc. | NASDAQ | $117.77 | $26.25B |
| TEVA | Teva Pharmaceutical Industries Limited | NYSE | $23.43 | $23.86B |